Pharmacist Moms Group^™

In this episode, the panel explains how VMAT2 inhibitors became the foundation of modern tardive dyskinesia treatment.

Healthcare professionals discuss effective management strategies for breakthrough bleeding, emphasizing updated protocols and patient education for optimal outcomes.

This episode outlines all treatment approaches available for tardive dyskinesia and how they are applied in practice.

Explore the evolving landscape of bleeding management with new rebalancing agents, emphasizing lower doses and effective treatment strategies.

Plozasiran offers a novel RNA-based mechanism to significantly reduce triglyceride levels in patients with familial chylomicronemia syndrome.

Ben Long, MD, and Weston Blakeslee, PhD, explain how personalized text messaging helps overcome common adherence barriers and keeps patients engaged without overwhelming them.

Heidi De Souza discusses strategies to enhance RSV vaccine uptake among older adults, emphasizing awareness, coadministration patterns, and public health efforts.

Discover how ENAMEL revolutionizes oral care with eco-friendly, waterless toothpaste tablets made from clean, natural ingredients.

Explore how real-world evidence shapes myelofibrosis treatment, focusing on biomarker utilization and safety profiles of JAK inhibitors.